Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein family A (Hsp70) member 9, also known as mortalin, is a ubiquitous mitochondrial chaperone protein encoded by the HSPA9 gene in humans. Mortalin is a member of the HSP70 family and has essential roles in mitochondrial protein folding, import, and quality control, mitochondrial biogenesis, iron-sulfur cluster biogenesis, and regulation of key cellular processes including apoptosis, proliferation, and response to stress. Mortalin is expressed in multiple cellular compartments (mitochondria, cytoplasm, nucleus, ER, sometimes extracellularly). It interacts with a wide range of partners such as p53, FGF1, Dj-1, and components of the mitochondrial import machinery. Mortalin has been implicated in cancer (especially in oncogenic cell survival and resistance to apoptosis), and neurodegenerative diseases such as Alzheimer's and Parkinson's disease, where it may affect protein misfolding, oxidative stress, and mitochondrial function. Mortalin is emerging as a therapeutic target, especially in cancers with aberrant MEK-ERK signaling (like BRAF-mutant tumors), and experimental drugs such as MKT-077 and HSP70 inhibitors have been used to explore this avenue. However, due to its central homeostatic roles, therapeutic targeting poses significant safety and toxicity challenges.
Inhibition of chaperone activity (e.g., MKT-077 inhibits mortalin, leading to cell death in cancer lines) Disruption of mortalin’s stabilization of p53, mitochondrial integrity, and anti-apoptotic functions
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family A (Hsp70) member 9 (HSPA9).